Comprehensive analysis of the diagnostic and therapeutic value of the hypoxia-related gene PLAUR in the progression of atherosclerosis

[1]  A. Torkamani,et al.  Decoding the transcriptome of calcified atherosclerotic plaque at single-cell resolution , 2022, Communications Biology.

[2]  Xin Wang,et al.  The Integrated Analysis Identifies Three Critical Genes as Novel Diagnostic Biomarkers Involved in Immune Infiltration in Atherosclerosis , 2022, Frontiers in Immunology.

[3]  Yanting Song,et al.  The role of hypoxia-inducible factors in cardiovascular diseases. , 2022, Pharmacology & therapeutics.

[4]  J. Lindholt,et al.  Lipocalin-2 and Calprotectin Potential Prognosis Biomarkers in Peripheral Arterial Disease. , 2022, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[5]  Chengming Fan,et al.  Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from coronary artery disease , 2022, Journal of cellular and molecular medicine.

[6]  Joël M. H. Karel,et al.  Integrative multiomics analysis of human atherosclerosis reveals a serum response factor‐driven network associated with intraplaque hemorrhage , 2021, Clinical and translational medicine.

[7]  J. Weaver,et al.  Upregulated anti-angiogenic miR-424-5p in type 1 diabetes (model of subclinical cardiovascular disease) correlates with endothelial progenitor cells, CXCR1/2 and other parameters of vascular health , 2021, Stem Cell Research & Therapy.

[8]  Xiao-Hua Yu,et al.  Biochanin A Mitigates Atherosclerosis by Inhibiting Lipid Accumulation and Inflammatory Response , 2020, Oxidative medicine and cellular longevity.

[9]  Wanzun Lin,et al.  Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups , 2020, Frontiers in Oncology.

[10]  Huanhuan Gao,et al.  Proteomic and Metabolomic Characterization of COVID-19 Patient Sera , 2020, Cell.

[11]  R. Krauss,et al.  Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel , 2020, European heart journal.

[12]  John A. Bohlin,et al.  Statistical predictions with glmnet , 2019, Clinical Epigenetics.

[13]  Yanhua Zheng,et al.  Identification of potential hub‐lncRNAs in ischemic stroke based on Subpathway‐LNCE method , 2019, Journal of cellular biochemistry.

[14]  M. Bennett,et al.  Vascular smooth muscle cells in atherosclerosis , 2019, Nature Reviews Cardiology.

[15]  Clint L. Miller,et al.  Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis , 2019, Nature Medicine.

[16]  Wenjing Zhang,et al.  Neprilysin Inhibitor–Angiotensin II Receptor Blocker Combination Therapy (Sacubitril/valsartan) Suppresses Atherosclerotic Plaque Formation and Inhibits Inflammation in Apolipoprotein E- Deficient Mice , 2019, Scientific Reports.

[17]  Ying Huang.  The novel regulatory role of lncRNA‐miRNA‐mRNA axis in cardiovascular diseases , 2018, Journal of cellular and molecular medicine.

[18]  A. Lichtman,et al.  Monocyte-Macrophages and T Cells in Atherosclerosis. , 2017, Immunity.

[19]  Qingbo Xu,et al.  Hypoxia inducible factor as a therapeutic target for atherosclerosis. , 2017, Pharmacology & therapeutics.

[20]  D. Bluemke,et al.  Bridging the gap for lipid lowering therapy: plaque regression, coronary computed tomographic angiography, and imaging-guided personalized medicine , 2017, Expert review of cardiovascular therapy.

[21]  J. Aerts,et al.  SCENIC: Single-cell regulatory network inference and clustering , 2017, Nature Methods.

[22]  L. Tavazzi,et al.  Distinct gene expression profiles associated with Notch ligands Delta-like 4 and Jagged1 in plaque material from peripheral artery disease patients: a pilot study , 2017, Journal of Translational Medicine.

[23]  Pornpimol Charoentong,et al.  Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade , 2016, bioRxiv.

[24]  De-feng Pan,et al.  Luteolin Attenuates Foam Cell Formation and Apoptosis in Ox-LDL-Stimulated Macrophages by Enhancing Autophagy , 2016, Cellular Physiology and Biochemistry.

[25]  M. Bilban,et al.  Common dysregulated pathways in obese adipose tissue and atherosclerosis , 2016, Cardiovascular Diabetology.

[26]  I. Komuro,et al.  HIF-1α-PDK1 axis-induced active glycolysis plays an essential role in macrophage migratory capacity , 2016, Nature Communications.

[27]  C. Fernández-Hernando,et al.  Age‐associated vascular inflammation promotes monocytosis during atherogenesis , 2016, Aging cell.

[28]  Ruth Huey,et al.  Computational protein–ligand docking and virtual drug screening with the AutoDock suite , 2016, Nature Protocols.

[29]  T. Blondal,et al.  Differential expression of plasma miRNAs in patients with unprovoked venous thromboembolism and healthy control individuals. , 2015, Thrombosis research.

[30]  E. Edelman,et al.  miRNAs in atherosclerotic plaque initiation, progression, and rupture. , 2015, Trends in molecular medicine.

[31]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[32]  J. Michel,et al.  Pathology of human plaque vulnerability: mechanisms and consequences of intraplaque haemorrhages. , 2014, Atherosclerosis.

[33]  K. Moore,et al.  Macrophages in atherosclerosis: a dynamic balance , 2013, Nature Reviews Immunology.

[34]  G. Bricca,et al.  Identification of two genes potentially associated in iron-heme homeostasis in human carotid plaque using microarray analysis , 2013, Journal of Biosciences.

[35]  Justin Guinney,et al.  GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.

[36]  S. Erzurum,et al.  Endothelial Apelin-FGF Link Mediated by MicroRNAs 424 and 503 is Disrupted in Pulmonary Arterial Hypertension , 2012, Nature Medicine.

[37]  Hongjian Li,et al.  Prostaglandin E1 dose-dependently promotes stability of atherosclerotic plaque in a rabbit model. , 2012, Canadian journal of physiology and pharmacology.

[38]  W. Wong,et al.  Hypoxia-inducible factors and the response to hypoxic stress. , 2010, Molecular cell.

[39]  Matthew D. Wilkerson,et al.  ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking , 2010, Bioinform..

[40]  G. Getz,et al.  Lymphotoxin β receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE−/− mice , 2009, The Journal of experimental medicine.

[41]  S. Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[42]  Mathijs Groeneweg,et al.  Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. , 2008, Journal of the American College of Cardiology.

[43]  P. V. van Diest,et al.  HIF-1 alpha expression is associated with an atheromatous inflammatory plaque phenotype and upregulated in activated macrophages. , 2007, Atherosclerosis.

[44]  R. Flavell,et al.  Natural regulatory T cells control the development of atherosclerosis in mice , 2006, Nature Medicine.

[45]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Jean-Daniel Zucker,et al.  Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. , 2005, Diabetes.

[47]  Kyung-Hee Lee,et al.  Involvement of MAPK pathway in hypoxia-induced up-regulation of urokinase plasminogen activator receptor in a human prostatic cancer cell line, PC3MLN4 , 2004, Experimental & Molecular Medicine.

[48]  J. Fleshman,et al.  Obesity Decreases Perioperative Tissue Oxygenation , 2004, Anesthesiology.

[49]  Hari Prasad Devkota,et al.  Curcumin, the golden spice in treating cardiovascular diseases. , 2019, Biotechnology advances.

[50]  S. Houser,et al.  Caspase-1 mediates hyperlipidemia-weakened progenitor cell vessel repair. , 2016, Frontiers in bioscience.